8May
Uncategorized
Invictus MD announces $20,000,000 Bought Deal Private Placement of Units

VANCOUVER, BC, May 08, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces it has determined not to proceed with its previously announced offering of convertible debentures as set forth in a news release dated April 20, 2017 and instead will proceed with an offering of […]

Read more

5May
Uncategorized
Invictus MD to Open the Market at TSX Venture Exchange on May 5

VANCOUVER, BC, May 5, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce that its management team will visit TSX Venture Exchange (TSXV) on May 5, 2017 and will be opening the trading day. “When we open the trading day, we […]

Read more

26Apr
Uncategorized
Invictus MD completes acquisition of Acreage Pharms Ltd. a Licensed Producer of Cannabis under the ACMPR

Vancouver, BC, April 26, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has acquired 100% of the shares of Acreage Pharms Ltd. (“Acreage Pharms”), a licensed producer of Cannabis under the Access to Cannabis for Medicinal Purposes Regulations (“ACMPR”). The […]

Read more

20Apr
Investor Relations
Invictus MD announces $40,000,000 Bought Deal Private Placement of Convertible Debentures and notice of intention to exercise option on Acreage Pharms

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, April 20, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announced today that it has engaged Canaccord Genuity Corp. and Eventus Capital Corp., as co-lead underwriters and joint-bookrunners, […]

Read more

19Apr
Investor Relations
Canopy Growth Corporation Enters Into An Agreement with Invictus MD’s AB Laboratories For Cannabis Sales

VANCOUVER, BC, April 19, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), will provide their unique products in Canopy Growth Corporation’s (TSX:WEED) (“Canopy […]

Read more

13Apr
Investor Relations
Invictus MD’s Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector

VANCOUVER, BC, April 13, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.787 million in revenue for the 9 months ending March 31, 2017, with a […]

Read more

11Apr
Investor Relations
Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis

Vancouver, BC, April 11, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. (“Acreage Pharms”) which Invictus MD has the option to now acquire 100 percent and expect to exercise in short order, begins their new cultivation cycle, having received their license […]

Read more

5Apr
Investor Relations
Invictus MD’s Chairman Provides March in Review

VANCOUVER, BC, April 5, 2017 – INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s Cannabis Company, is pleased to provide a month in review. March was a transformational time for Invictus MD as it worked to expand and solidify its cultivation portfolio with expansion plan forecasts of 50,000 kilograms of high quality […]

Read more

31Mar
Investor Relations
Invictus MD Moves To TSX Venture Exchange

VANCOUVER, BC, March 30, 2017 – INVICTUS MD STRATEGIES CORP. (TSXV:IMH) (“Invictus MD” or the “Company”), Canada’s cannabis company, is pleased to announce that its common shares will be delisted from the Canadian Securities Exchange after the close of trading on March 30, 2017 and will be listed on the TSX Venture Exchange (“TSXV“) commencing at […]

Read more

31Mar
Investor Relations
Invictus MD Announces OptionCo Has Received its License to Cultivate under ACMPR

Vancouver, BC, March 30, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that OptionCo has received its license to cultivate under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) as Acreage Pharms Ltd. (“Acreage Pharms”). “This is a historic day for our Company, our […]

Read more

29Mar
Investor Relations
Invictus MD Appoints Interim Chief Financial Officer

VANCOUVER, BC, March 29, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce that Herrick Lau has been appointed as interim CFO. Mr. Lau who was a previous director of Invictus MD, and currently is the Managing Director of Baron Global Financial […]

Read more

28Mar
Investor Relations
Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market

VANCOUVER, BC, March 28, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to provide an update of its production capability in preparation for the recreational cannabis market. Marijuana could be legal in Canada by July 1, 2018; according to CBC News, they […]

Read more

27Mar
Investor Relations
Invictus MD Announces Conditional Approval to List on the TSX Venture Exchange

VANCOUVER, BC, March 27, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce it has received conditional approval to list its common shares for trading on the TSX Venture Exchange. Receiving the conditional listing approval from the TSXV follows a year […]

Read more

24Mar
Investor Relations
Invictus MD Appoints Global Strategic Leader to Board of Directors

VANCOUVER, BC, March 24, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD announced today that Mr. George E Kveton has been appointed to the Company’s Board of Directors. Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad […]

Read more

23Mar
Investor Relations
Invictus MD’s AB Laboratories Inc. Provides Cultivation Update under ACMPR

VANCOUVER, BC, March 23, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD announces that AB Laboratories Inc. (“AB Labs”) has successfully completed several test crops in its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) located in Hamilton, Ontario. […]

Read more

14Mar
Investor Relations
Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.

VANCOUVER, BC, March 14, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has completed its final commitment with a cash transaction of CAD$2,000,000 to acquire 33.33% of AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis […]

Read more

9Mar
Investor Relations
Invictus MD’s Chairman and CEO Granted Stock Options

VANCOUVER, BC, March 9, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Mr. Dan Kriznic, director of Invictus MD Strategies Corp. (the “Issuer”), announces that on March 2, 2017, he was granted stock options (the “Options”) to purchase 1,000,000 common shares of the Issuer exercisable at […]

Read more

7Mar
Investor Relations
Invictus MD’s Future Harvest Achieves Increase In Gross Margin Resulting From Increased Fertilizer Sales In The Cannabis-Centric Space

VANCOUVER, BC, March 7, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.578 million in revenue for the 8 months ending February 28, 2017, with a […]

Read more

2Mar
Investor Relations
Invictus MD Announces Granting of Stock Options

VANCOUVER, BC, March 2, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) reports that it has granted 1,250,000 incentive stock options to directors, officers and consultants of the Company. The stock options are exercisable for a period of five years at an exercise price of $1.75 […]

Read more

2Mar
Investor Relations
Invictus MD Closes $16,218,065 Bought Deal Private Placement

Vancouver, BC, March 2, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed its previously announced bought deal private placement (the “Offering”), with Canaccord Genuity Corp. and Eventus Capital Corp. (collectively, the “Underwriters”), including a portion of the over-allotment […]

Read more

25Feb
Investor Relations
Invictus MD announces definitive option agreement with Late Stage Applicant under the ACMPR

VANCOUVER, BC, February 24, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that further to its news release dated February 7, 2017 it has successfully entered into a definitive option agreement with a Late Stage Applicant (“OptionCo”) under the Access to Cannabis […]

Read more

15Feb
Investor Relations
Invictus MD’s Future Harvest Achieves 63% Increase In Gross Margin For The Past 7 Months

VANCOUVER, BC, February 15, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.423 million in revenue for the 7 months ending January 31, 2017, with a […]

Read more

10Feb
Investor Relations
Invictus MD Announces $15,015,000 Bought Deal Private Placement of Units

VANCOUVER, BC, February 10, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce today that it has entered into an agreement with Canaccord Genuity Corp. and Eventus Capital Corp. as co-lead underwriters (collectively, the “Underwriters”) pursuant to which the Underwriters have agreed to […]

Read more

9Feb
Investor Relations
Invictus MD announce that AB Ventures Inc. has acquired 100 acres for future cannabis cultivation and sale under the ACMPR

VANCOUVER, BC, February 9, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Ventures Inc. (“AB Ventures”), a newly incorporated company formed to develop a second licensed expansion facility through it’s common ownership with AB Laboratories Inc. (“AB Labs”), a Licensed […]

Read more

8Feb
Investor Relations
Invictus MD Strategies Corp. and Reliq Health Technologies Sign MOU to Collaborate on App for Cannabis Prescribers, Patients and Consumers

VANCOUVER, BC, February 8, 2017 – Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) (“Invictus MD”) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Reliq Health Technologies. (“Reliq”) (TSXV: RHT; OTC: RQHTF) to develop a mobile application for cannabis patients and consumers and their clinical care […]

Read more

7Feb
Investor Relations
Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

VANCOUVER, BC, February 7, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late […]

Read more

26Jan
Investor Relations
Invictus MD Strategies Corp. CEO’s Update to Shareholders

VANCOUVER, BC, January 26, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Chairman and CEO Dan Kriznic is pleased to provide this update to it’s shareholders. 2016 was a transformational year for Invictus MD. The Company’s majority interest in Future Harvest Development Ltd. (“FHD”), initially purchased […]

Read more

24Jan
Investor Relations
Invictus MD Strategies Corp. Announces the Appointment of Larry Heinzlmeir as Vice President, Marketing and Communications

VANCOUVER, BC, January 24, 2017 – INVICTUS MD STRATEGIES CORP. (Invictus MD) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that Larry Heinzlmeir has joined the company as Vice President of Marketing and Communication, reporting to Chairman and CEO Dan Kriznic. Heinzlmeir is an authority on digital marketing, online platforms and brand strategy. […]

Read more

17Jan
Investor Relations
Invictus MD announces binding LOI to acquire PlanC BioPharm Inc., a Late Stage Applicant under Health Canada’s ACMPR

VANCOUVER, BC, January 17, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has entered into a binding letter of intent (“LOI”) to acquire 100% of PlanC BioPharm Inc. (“PlanC”), a Late Stage Applicant under the Access to Cannabis for Medical […]

Read more

29Dec
Investor Relations
Invictus MD closes acquisition of shares in ACMPR Licensed Producer AB Laboratories Inc.

VANCOUVER, BC, December 29, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed the acquisition of 33.33% of the shares of AB Laboratories Inc. and the initial acquisition of shares of AB Ventures Inc., as previously announced on December […]

Read more

23Dec
Investor Relations
Invictus MD closes acquisition of ACMPR Licensed Producer AB Laboratories Inc.

VANCOUVER, BC, December 23, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has signed the definitive agreement to acquire 33.33% of AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), and […]

Read more

12Dec
Investor Relations
Invictus MD hires top tier cannabis consultants and Chief Science Officer for North America wide conquest

Vancouver, BC, December 12, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce it has entered into a consulting agreement with Cannera Consultants (“Cannera”) and has enlisted Phillip Hague to undertake the role of Chief Science Officer and Head of Horticulture. Cannera, a […]

Read more

7Dec
Investor Relations
Invictus MD announces binding Letter of Intent to acquire 20% Washington i502 Cultivation & Processing License

Vancouver, BC, December 7, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce it has entered into a binding Letter of Intent to acquire a Tier 2 State of Washington Cultivation and Processing License (”The Operation”). Invictus MD will pay $1,000,000 USD cash […]

Read more

7Dec
Investor Relations
Invictus MD pays $1 million Dividend

Vancouver, BC, December 5, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it has paid a $1 million dividend to shareholders as of record on November 21, 2016. Dan Kriznic, CEO commented “The payment of this dividend marks a milestone in our overall strategy […]

Read more

25Nov
Investor Relations
Invictus MD Selected Top 25 Long Term Stock Buys by CANNAINVESTOR Magazine

Vancouver, BC, November 25, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce they will be listed as one of the top 25 long-term stock buys within the cannabis industry according to CANNAINVESTOR Magazine. Invictus MD and Future Harvest will be featured as […]

Read more

24Nov
Investor Relations
Invictus MD announces increase in private placement to up to $12,000,000

Vancouver, BC, November 24th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that due to robust demand, the Company is increasing the size of its private placement of units announced earlier today to up to CAD$12,000,000. For further details on the private […]

Read more

24Nov
Investor Relations
Invictus MD announces binding LOI to acquire Health Canada Licensed Producer under the ACMPR and concurrent $10,000,000 private placement

Vancouver, BC, November 24th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has entered into a binding letter of intent to acquire 33 1/3% of AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical […]

Read more

22Nov
Investor Relations
Dr. Paul Shipley of University of British Columbia to Join Future Harvest Development as Research and Development Consultant

Vancouver, BC, November 22, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) has successfully retained the services of Dr. Paul Shipley of the University of British Columbia (“UBC”) for the role of Research and Development Consultant for the Future Harvest Development (“FHD”) Product Development and Special […]

Read more

22Nov
Investor Relations
Invictus MD closes option to acquire Las Vegas cultivation license

Vancouver, BC, November 22, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed an option agreement (the “Option”) to acquire up to 60% in a State of Nevada (“SNV”) Medical Marijuana Cultivation License located in Las Vegas, Nevada (the […]

Read more

18Nov
Investor Relations
Invictus MD closes 49% option on cannabis testing lab as part of North American cannabis lab roll up strategy

Vancouver, BC, November 18, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has finalized and closed the option agreement (the “Option”) to acquire 49% of Zenalytic Laboratories Inc. (“Zen Labs”), located in Kelowna, BC, and a subsidiary of the GreenTec […]

Read more

10Nov
Investor Relations
Invictus MD Embraces the Expansion of Legalized Marijuana within the U.S. following Statewide Ballot Results

Vancouver, BC, November 10, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce intentions for expansion following the legalization of recreational cannabis in California, Massachusetts, and Nevada and of medical cannabis in Arkansas, Florida, Montana, and North Dakota following statewide ballots held November […]

Read more

8Nov
Investor Relations
Invictus MD’s PODA anticipating Spring 2017 Launch

Vancouver, BC, November 8, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly-owned subsidiary, Poda Technologies Ltd. (“Poda”) (formerly The Edison Vape Co. Ltd.) is currently in the final stages of development and is anticipating a Spring 2017 launch. Ryan […]

Read more

7Nov
Investor Relations
Invictus MD Amends Dividend Dates

Vancouver, BC, November 7, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that its Board of Directors have decided to change the timing of the dividend payout previously announced in its news release dated October 11, 2016. The cash dividend of $1 million will be […]

Read more

27Oct
Investor Relations
Invictus MD enters into a LOI to acquire Las Vegas cultivation license

Vancouver, BC, October 27, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has entered into a Letter of Intent for an option to acquire 10% in an unnamed State of Nevada (“SNV”) Medical Marijuana Cultivation License located in Las Vegas […]

Read more

24Oct
Investor Relations
Invictus MD enters into a LOI to acquire Cannabis Testing Laboratory

Vancouver, BC, October 24, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has entered into a Letter of Intent for an option to acquire 49% of Zenalytic Laboratories Inc. (“Zen Labs”), a wholly owned subsidiary of the GreenTec BioPharmaceuticals Corporation […]

Read more

21Oct
Investor Relations
Future Harvest Collaborates with UBC Kelowna to Progress Plant Growth

Vancouver, BC, October 21, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that Future Harvest Development Ltd. (“Future Harvest”), is working directly with The University of British Columbia Kelowna Campus (“UBC Kelowna”) to secure grants for various topics in plant research. One […]

Read more

11Oct
Investor Relations
Invictus MD announces $1 million Dividend

Vancouver, BC, October 11, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its Board of Directors have approved the payment of a cash dividend of $1 million. This represents $0.108 per share based on the current number of shares issued and […]

Read more

7Oct
Investor Relations
Invictus MD’s Future Harvest Achieves 50% year over year growth in revenue

50% year over year growth in revenue Vancouver, BC, October 7, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has achieved $587,800 in revenue for the three months […]

Read more

20Sep
Uncategorized
Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Read more

18Aug
Investor Relations
Invictus Achieves EBITDA Milestones

Vancouver, BC, August 18th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) reports that it has issued an aggregate of 1,400,275 common shares to certain shareholders, including directors, officers, and consultants. A total of 1,139,275 common shares were converted from 113,926 Class A Preferred Shares on a ten to […]

Read more

11Mar
Investor Relations
Invictus MD Announces Share Consolidation

Vancouver, BC, March 11, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it is proceeding with a consolidation of its issued and outstanding share capital on the basis of one post-consolidated common share for every ten pre-consolidated common shares.  No fractional shares will be […]

Read more

9Mar
Investor Relations
Invictus MD’s Edison Vape Co. Receives Prototype and Continues Patent Process

Vancouver, BC, March 9, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly-owned subsidiary, Edison Vape Co. Ltd. (“Edison”) has received pre-production samples of the Edison device and functional testing has been started. Preliminary testing has indicated extremely positive results […]

Read more

4Feb
Investor Relations
Invictus MD’s Future Harvest Achieves Highest Single Month Sales in History

Vancouver, BC, February 4, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 75%, has achieved their highest single month of sales in history, totalling approximately $800,000 during the month […]

Read more

2Feb
Investor Relations
Invictus MD’s Future Harvest Achieves Highest December Sales in History

Vancouver, BC, February 2, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 75%, has achieved their highest sales ever in the month of December, totalling $678,958 during the month […]

Read more

1Feb
Investor Relations
Invictus Announces Sale of Product Line for Approximately $4.8 Million Cash Consideration

Vancouver, BC, February 1, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 75% indirectly through its subsidiary Prestige Worldwide Holdings Inc., has entered into an asset purchase agreement (the […]

Read more

1Feb
Investor Relations
Invictus Acquires 75% of Future Harvest

Vancouver, BC, February 1, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has acquired, indirectly through its subsidiary, Prestige Worldwide Holdings Inc., an additional 15% of the shares of Future Harvest Development Ltd. (“Future Harvest”) pursuant to the purchase and […]

Read more

23Dec
Investor Relations
Invictus MD Achieves $1,287,035 in Revenue For The Three Months Ended October 31, 2015

Vancouver, BC, December 23, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it has filed its consolidated financial statements and management’s discussion and analysis (the “Financial Statements”) for the three and nine months ended October 31, 2015, available for viewing on www.sedar.com. Dan Kriznic, […]

Read more

3Dec
Investor Relations
Invictus MD Announces Production Plans for Edison Vape

Vancouver, BC, December 3, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly-owned subsidiary, Edison Vape Co. Ltd. (“Edison”) has completed the production-ready designs of the Edison Vape devices and manufacturing of the required moulds and tooling equipment is now underway. […]

Read more

30Nov
Investor Relations
Invictus MD Announces Sale of Cannabis Health and Smokazon

Vancouver, BC, November 30, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it has sold its interest in Cannabis Health Sciences Inc. (“Cannabis Health”) and Focus Distribution LLC, operating as Smokazon.com (“Smokazon”) effective November 30, 2015 (the “Closing Date”). Dan Kriznic, President and CEO […]

Read more

10Nov
Investor Relations
Invictus MD’s Future Harvest Achieves 75% Increase In Sales Over Last Quarter

Vancouver, BC, November 10, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 60%, has continued to achieve record-breaking sales and is on pace to generate the targeted sales goal […]

Read more

4Nov
Investor Relations
Invictus MD Announces Proposed Spin-Out of Future Harvest Development Ltd.

Vancouver, BC, November 4, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that the Company has received approval from its board of directors to complete a spin-out of its interest in Future Harvest Development Ltd. (“Future Harvest”) into a newly formed public […]

Read more

2Nov
Investor Relations
Invictus MD Announces Acquisition of 100% of Edison Vape Co. Ltd.

Vancouver, BC, November 2, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that, pursuant to the initial agreement announced on January 27, 2015, between the Company and the original founders and inventors of Edison Vape Co. Ltd. (“Edison”), being Ryan Selby and Ryan Karkhairan (the […]

Read more

28Oct
Investor Relations
Invictus MD Announces Completion of Share Exchange

Vancouver, BC, October 28, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that, further to its news release dated June 25, 2015, it has entered into a share exchange agreement dated October 26, 2015 with certain escrowed shareholders whereby 17,089,121 escrowed common shares (the “Escrow […]

Read more

1Oct
Investor Relations
Invictus MD Announces $4.6 Million in Assets on Second Quarter Balance Sheet

Vancouver, BC, October 1, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it has filed its condensed interim consolidated financial statements and management’s discussion and analysis (the “Financial Statements”) for the six months ended July 31, 2015 (the “Second Quarter”), available for viewing on […]

Read more

16Sep
Investor Relations
Future Harvest Development Releases New Products

Vancouver, BC, September 16, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to provide an update on Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD owns 60%, and their newly expanded line-up of products for the fall season. Wicking Gardens This year […]

Read more

10Sep
Investor Relations
Future Harvest Development Kicks Off Its Annual Lawn & Garden Trade and Buying Show Season

Vancouver, BC, September 10, 2015 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to provide an update on Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD owns 60%, as the fall lawn and garden show season begins. During the month of August, Future […]

Read more